Project Grant R01GM158685
Award Date
7/1/25
Completion Date
4/30/29
Dollars Obligated
$366K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $462,000.00 to the Albert Einstein College of Medicine to conduct research on the epigenetic regulation of embryonic stem cell biology by TET enzymes. The key objectives are to: Dissect the molecular and biological requirements of TET-driven DNA hydroxylation versus formylation/carboxylation in embryonic stem cell...
The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Federal Grant Program (CFDA 93.859), awarded a $1,218,750 Project Grant to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant, with a period of performance from August 1, 2024 to May 31, 2029, will support research to characterize the regulatory networks and mechanisms of developmentally regulated...
This Project Grant award of $1,199,999.00 from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research on DNA N6-adenine methylation (6mA) in the unicellular eukaryote Tetrahymena thermophila. The research aims to provide insights into the molecular mechanisms governing 6mA, a recently discovered epigenetic mark in eukaryotes, and its role in gene regulation. Advanced DNA sequencing techniques will be used to map 6mA across the Tetrahymena genome, and...
This Project Grant award of $406,250.00 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to investigate the role of mechanical cues in the extracellular matrix in regulating monocyte inflammation. The project aims to develop human stem cell-based culture systems for studying monocyte mechanobiology, investigate the mechanical regulation of non-canonical NF-kappa-B signaling both in vitro...
The National Institute of General Medical Sciences (NIGMS) awarded a $294,647 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Texas at Dallas (UTD). The grant will fund a 4-year project from September 1, 2024 to August 31, 2028 to develop a theoretical, computational, and experimental framework for modeling epigenetic regulatory networks in human cells. The key objectives are to rapidly assemble and stably integrate libraries of...
This Project Grant award of $1,218,750 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will support research at the University of Pennsylvania to develop new protein-engineered biomaterials and bioorthogonal chemistries to study cellular mechanosensing. The research aims to decouple the influences of matrix stiffness, viscous force dissipation, and adhesive cues on fundamental cellular processes like...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $406,250.00 in funding to The Trustees of the University of Pennsylvania, with a period of performance from June 1, 2025 to April 30, 2030. The award supports research focused on two main directions: 1) understanding how transcription factor families coordinate complex developmental pathways to generate diverse...
The National Institute of General Medical Sciences (NIGMS) awarded a $406,250 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) federal grant program to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. This 5-year award, effective January 22, 2025, supports research to implement a "nascent extracellular matrix" into engineered in vitro cellular systems, in order to better understand...
This federal Project Grant award from the National Institute of General Medical Sciences (CFDA 93.859 - Biomedical Research and Research Training) provides $406,250.00 to The Trustees of the University of Pennsylvania over a 5-year period from August 15, 2024 to July 31, 2029. The research focuses on mapping the post-transcriptional aspects of gene expression, with a specific emphasis on understanding alternative ribosome initiation and the role of RNA modifications and binding proteins in...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of engineered enzymes that can be activated to perform targeted modifications of cellular proteins. The $1,602,000 award to the Dana-Farber Cancer Institute, Inc. (DFCI) will fund research to design and apply novel autoinhibited enzymes that can toggle between inactive and active conformations in response...